1. Home
  2. HXHX vs NXL Comparison

HXHX vs NXL Comparison

Compare HXHX & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HXHX
  • NXL
  • Stock Information
  • Founded
  • HXHX 2003
  • NXL 2010
  • Country
  • HXHX China
  • NXL United States
  • Employees
  • HXHX N/A
  • NXL N/A
  • Industry
  • HXHX Trucking Freight/Courier Services
  • NXL Medical Specialities
  • Sector
  • HXHX Industrials
  • NXL Health Care
  • Exchange
  • HXHX Nasdaq
  • NXL Nasdaq
  • Market Cap
  • HXHX 13.3M
  • NXL 14.0M
  • IPO Year
  • HXHX 2025
  • NXL 2022
  • Fundamental
  • Price
  • HXHX $1.36
  • NXL $0.88
  • Analyst Decision
  • HXHX
  • NXL Strong Buy
  • Analyst Count
  • HXHX 0
  • NXL 1
  • Target Price
  • HXHX N/A
  • NXL $5.00
  • AVG Volume (30 Days)
  • HXHX 222.9K
  • NXL 2.9M
  • Earning Date
  • HXHX 01-01-0001
  • NXL 11-07-2025
  • Dividend Yield
  • HXHX N/A
  • NXL N/A
  • EPS Growth
  • HXHX N/A
  • NXL N/A
  • EPS
  • HXHX 0.26
  • NXL N/A
  • Revenue
  • HXHX $25,571,810.00
  • NXL $174,813.00
  • Revenue This Year
  • HXHX N/A
  • NXL $38.28
  • Revenue Next Year
  • HXHX N/A
  • NXL $185.71
  • P/E Ratio
  • HXHX $5.29
  • NXL N/A
  • Revenue Growth
  • HXHX N/A
  • NXL 16.42
  • 52 Week Low
  • HXHX $0.84
  • NXL $0.59
  • 52 Week High
  • HXHX $6.29
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • HXHX N/A
  • NXL 49.35
  • Support Level
  • HXHX N/A
  • NXL $0.79
  • Resistance Level
  • HXHX N/A
  • NXL $0.99
  • Average True Range (ATR)
  • HXHX 0.00
  • NXL 0.08
  • MACD
  • HXHX 0.00
  • NXL 0.01
  • Stochastic Oscillator
  • HXHX 0.00
  • NXL 45.71

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: